News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Hepatitis C Action Plan released


Media Release

29 October 2002

Hepatitis C Action Plan released

TODAY the Ministry of Health releases Action on Hepatitis C Prevention, a plan to minimise the spread of hepatitis C in New Zealand.

"We've taken an important step in answering the strong and ongoing demand for action on preventing hepatitis C. The transmission of hepatitis C, a viral infection of the liver, is a global health concern," said Ministry spokesperson Dr Douglas Lush.

"It is difficult to determine how many people have hepatitis C. However, worldwide it has been estimated that 170 million or about three percent of the world population are infected with the virus. Around three-four million people are newly infected each year with the virus."

It has been estimated that approximately 25,000 New Zealanders are currently infected with hepatitis C and this number is predicted to increase by 50 percent over the next ten years, said Dr Lush, Public Health Senior Advisor.

"Hepatitis C is transmitted through exposure to infected blood. With today's high safety standards associated with our blood and blood products, the risks of transfusion-transmitted infections in New Zealand are extremely low. The greatest risk for transmission of hepatitis C is through blood-to-blood contact involved with injecting drug use," said Dr Lush.

Dr Lush said the use of illicit drugs by injection has become the single most important risk factor for acquiring hepatitis C and accounts for around 80 percent of infections.

Therefore, "reducing hepatitis C transmission in injecting drug users is the highest priority," he said. "Another priority is developing a hepatitis C resource manual for stakeholders and health providers."

The action plan shows what has to be done in order to reduce both the transmission and the personal and social impacts of hepatitis C. A discussion document and focus group meetings with stakeholders preceded the final development of the action plan. The consultation process showed widespread support for the importance of defining priorities for the future.

The Action on Hepatitis C Prevention is available on the Ministry of Health web site (www.moh.govt.nz/cd/hepc).

ENDS

For more information contact:

Kim Purdy Media Advisor Government & Sector Relations\Communications Corporate & Information Directorate Ministry of Health DDI: 04 496 2483 Mobile: 025 277 5411 Fax: 04 496 2010

http://www.moh.govt.nz mailto:kim_purdy@moh.govt.nz

BACKGROUND

Hepatitis C is primarily spread by contact with infected human blood and, previously, unscreened blood and blood products were a major source of infection. Since the introduction of screening of donated blood in 1992, the risk of hepatitis C transmission in New Zealand through blood and blood products has become very remote.

Today the greatest risk of transmission is through blood to blood contact involved with injecting drug use. It is very difficult to estimate the number of injection drug users, but it has been estimated that approximately 13,500?26,600 people are opioid-dependent in New Zealand. As not all those who inject drugs are dependent or opioid users, the population risk is likely to be larger.

Minimising harm caused by alcohol and drug use is a priority in the New Zealand Health Strategy.

Acute hepatitis C infection usually produces only a mild illness, and is often totally asymptomatic. Research has shown that approximately 25 percent of people with hepatitis C will clear the virus within two to six months of becoming infected. The other 75 percent of people who do not clear the virus will have an ongoing, or chronic infection.

Chronic infection by hepatitis C can lead to years of ill health, reduced quality of life and in some instances, social isolation. About half of those with chronic infection will develop cirrhosis, liver failure or cancer of the liver. However, these developments can take over 20 years or longer to develop.

Although hepatitis C treatment with antiviral therapy can prevent progression to chronic liver disease, this therapy is limited by poor tolerability and poor efficacy. Other treatments are still in the early stages of development. Unlike hepatitis A and hepatitis B, there is currently no hepatitis C vaccine available and the development of an effective vaccine is not imminent.

The key to the control of hepatitis C therefore lies in prevention programmes focusing on those at risk of infection, and those who are already infected, to avoid further disease transmission.

Some of the current programmes for the control and prevention of hepatitis C include:

Provision of information to groups at risk about the risk of infection and means to reduce it;

Provision of safe, clean injecting equipment to injecting drug users through needle exchanges;

Provision of drug treatment programmes for injecting drug users;

Screening and testing of human blood for transfusion;

Application of standard precautions approach to minimise blood exposures in health care and other settings;

Identifying and testing people at risk; and

Providing information to people with hepatitis C about ways to limit transmission to others and to prevent co-morbidity.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Reuben Moss' Property is Theft! & Kaitani at The Physics Room

Property is Theft! continues Moss’ interest in the contemporary urban environment as a space controlled by pulsing and unequal flows of capital and labour. Kaitani features work by the University of Canterbury Fijian Students Association and Kulimoe’anga Stone Maka. More>>


Handcrafted Form: Rare Treasures From Japan

This unique exhibition at Expressions Whirinaki represents 90 everyday objects made by contemporary Japanese artisans who employ various traditional craft techniques made in regional workshops. The works used in daily life are crafted from raw materials with techniques appropriate to bringing out the best of its medium, balancing ease of use with aesthetic appeal. More>>

Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>

ALSO:

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland